Could ACB make deal with more than one conglomerate?Seems to me that ACB’s main focus is medical. So Johnson and Johnson could be the most likely candidate for buyout. But if not, could Acb handle another partner or two? Any investment would mean building dedicated sky facilities to handle any deal. They are expanding across the globe so fast that I can’t see how they will meet demand, let alone partner demands.
Think thats why cronos and hexo got the deals they got, because the partners can dictate and control the MJ company. ACB won’t be controlled by any third party now it seems. Double edge sword.
But main thing is, ACB will lead in profits for a long time, if not forever.